Kshitij Arora1, Ivan Chebib1, Lawrence Zukerberg1, Manoj Gandhi2, Miguel Rivera1, David Ting3, Vikram Deshpande1. 1. Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. 2. Affymetrix, Santa Clara, California. 3. Division of Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Abstract
BACKGROUND: Current immunohistochemical and in situ hybridization (ISH) assays are generally inconclusive for clonality unless plasmacytic differentiation is present. This study examined a series of cytology specimens and explored the ability of a branched-chain RNA (bRNA) ISH assay for immunoglobulin κ constant (IGKC) and immunoglobulin λ constant (IGLC) to detect a clonal population of B lymphocytes. METHODS: Pathology databases were used to identify fine-needle aspiration biopsies (n = 28) and exfoliative cytology samples (n = 20). Demographic, flow cytometry, and excision biopsy results were recorded. bRNA ISH was performed on the Leica Bond platform with the following probes: IGKC, IGLC, immunoglobulin λ-like polypeptide 5 (IGLL5), and a housekeeping gene (HKG). RESULTS: The bRNA ISH assay was validated with 30 surgical biopsies. On bRNA ISH, a clonal B-cell population (light-chain ratio > 10:1) was detected in 22 of 28 cases with a final diagnosis of lymphoma. In 2 cases, a κ predominance was present, although the ratio was <10:1. Eleven of the 17 κ-clonal lymphomas also expressed IGLL5, the latter recognized by the presence of an intranuclear signal. Two B-cell lymphomas lacked IGKC and IGLC, whereas 2 cases were negative for the HKG. In 12 of the 20 cases with reactive lymphoid tissue, bRNA ISH identified a polyclonal lymphoid population. No light-chain messenger RNA was detected in 6 cases (typically those associated with very few B cells). CONCLUSIONS: The automated bRNA ISH platform is a robust technique for detecting a clonal B-cell population in cytology material.
BACKGROUND: Current immunohistochemical and in situ hybridization (ISH) assays are generally inconclusive for clonality unless plasmacytic differentiation is present. This study examined a series of cytology specimens and explored the ability of a branched-chain RNA (bRNA) ISH assay for immunoglobulin κ constant (IGKC) and immunoglobulin λ constant (IGLC) to detect a clonal population of B lymphocytes. METHODS: Pathology databases were used to identify fine-needle aspiration biopsies (n = 28) and exfoliative cytology samples (n = 20). Demographic, flow cytometry, and excision biopsy results were recorded. bRNA ISH was performed on the Leica Bond platform with the following probes: IGKC, IGLC, immunoglobulin λ-like polypeptide 5 (IGLL5), and a housekeeping gene (HKG). RESULTS: The bRNA ISH assay was validated with 30 surgical biopsies. On bRNA ISH, a clonal B-cell population (light-chain ratio > 10:1) was detected in 22 of 28 cases with a final diagnosis of lymphoma. In 2 cases, a κ predominance was present, although the ratio was <10:1. Eleven of the 17 κ-clonal lymphomas also expressed IGLL5, the latter recognized by the presence of an intranuclear signal. Two B-cell lymphomas lacked IGKC and IGLC, whereas 2 cases were negative for the HKG. In 12 of the 20 cases with reactive lymphoid tissue, bRNA ISH identified a polyclonal lymphoid population. No light-chain messenger RNA was detected in 6 cases (typically those associated with very few B cells). CONCLUSIONS: The automated bRNA ISH platform is a robust technique for detecting a clonal B-cell population in cytology material.
Authors: Eugen C Minca; Hongwei Wang; Zhen Wang; Christopher Lanigan; Steven D Billings; Yuling Luo; Raymond R Tubbs; Xiao-Jun Ma Journal: J Cutan Pathol Date: 2014-12-15 Impact factor: 1.587
Authors: Raymond R Tubbs; Hongwei Wang; Zhen Wang; Eugen C Minca; Bryce P Portier; Aaron M Gruver; Christopher Lanigan; Yuling Luo; James R Cook; Xiao-Jun Ma Journal: Am J Clin Pathol Date: 2013-11 Impact factor: 2.493
Authors: Mohammad Shahid; Aysha Mubeen; Julie Tse; Sanjay Kakar; Adrian C Bateman; Darrell Borger; Miguel N Rivera; David T Ting; Vikram Deshpande Journal: Am J Surg Pathol Date: 2015-01 Impact factor: 6.394
Authors: P Zeppa; E Vigliar; I Cozzolino; G Troncone; M Picardi; A De Renzo; F Grimaldi; F Pane; A Vetrani; Lucio Palombini Journal: Cytopathology Date: 2010-02-01 Impact factor: 2.073
Authors: Pio Zeppa; Gilda Marino; Giancarlo Troncone; Franco Fulciniti; Amalia De Renzo; Marco Picardi; Giulio Benincasa; Bruno Rotoli; Antonio Vetrani; Lucio Palombini Journal: Cancer Date: 2004-02-25 Impact factor: 6.860
Authors: Ling Guo; Zhen Wang; Courtney M Anderson; Emerald Doolittle; Siobhan Kernag; Claudiu V Cotta; Sarah L Ondrejka; Xiao-Jun Ma; James R Cook Journal: Mod Pathol Date: 2017-10-20 Impact factor: 7.842